Detalhe da pesquisa
1.
Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
Dig Dis Sci
; 69(1): 228-234, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37943382
2.
Unusual presentation of jejunal adenocarcinoma and ovarian metastasis.
Rev Esp Enferm Dig
; 116(4): 225-226, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37170586
3.
Unusual presentation of biliopancreatic cancer as primary retroperitoneal tumor.
Rev Esp Enferm Dig
; 116(1): 57-58, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37073696
4.
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis. / Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).
Gastroenterol Hepatol
; 47(5): 522-552, 2024 May.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38311005
5.
Safe use of proton-pump inhibitors.
Rev Esp Enferm Dig
; 115(9): 475-479, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37522310
6.
Effectiveness and safety of ustekinumab dose escalation in Crohn's disease: a multicenter observational study.
Rev Esp Enferm Dig
; 115(12): 686-692, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37314131
7.
Pancreatic intraductal papillary mucinous neoplasm evolving into adenocarcinoma. Continual follow-up necessary.
Rev Esp Enferm Dig
; 2023 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37539534
8.
Perianal Paget's disease.
Rev Esp Enferm Dig
; 115(8): 461-462, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36412481
9.
Severe outbreak of ulcerative colitis and cerebral neoplasia. Difficult management in COVID time.
Rev Esp Enferm Dig
; 115(11): 657, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36926936
10.
The HLA-DQA1*05 genotype does not influence the clinical response to ustekinumab and vedolizumab.
Rev Esp Enferm Dig
; 115(11): 608-614, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37314124
11.
Optimizing treatment of mild to moderate ulcerative colitis: CU-forum Delphi consensus. / Optimización del tratamiento de la colitis ulcerosa leve a moderada: Consenso Delphi CU-Forum.
Gastroenterol Hepatol
; 46(10): 784-794, 2023 Dec.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-36803681
12.
Switch to subcutaneous infliximab during the SARS-CoV-2 pandemic: preliminary results.
Rev Esp Enferm Dig
; 114(2): 118-119, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34517718
13.
Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori.
Rev Esp Enferm Dig
; 114(2): 89-95, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33947195
14.
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.
Rev Esp Enferm Dig
; 114(5): 272-279, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33393332
15.
Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia.
Rev Esp Enferm Dig
; 114(9): 516-521, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35000397
16.
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.
Gastroenterol Hepatol
; 45(3): 165-176, 2022 Mar.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-34051313
17.
Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results.
Rev Esp Enferm Dig
; 113(2): 92-97, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33371692
18.
Vedolizumab response in inflammatory bowel disease. Two years of follow-up.
Rev Esp Enferm Dig
; 112(7): 555-558, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32579005
19.
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA study.
Rev Esp Enferm Dig
; 112(9): 675-681, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32894023
20.
National survey on the experiences of people with celiac disease in Spain. The CELIAC-SPAIN project.
Rev Esp Enferm Dig
; 112(5): 343-354, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32338009